116 related articles for article (PubMed ID: 8177922)
1. Dopamine D2 and serotonin S2 receptors in susceptibility to methamphetamine psychosis detected by positron emission tomography.
Iyo M; Nishio M; Itoh T; Fukuda H; Suzuki K; Yamasaki T; Fukui S; Tateno Y
Psychiatry Res; 1993 Dec; 50(4):217-31. PubMed ID: 8177922
[TBL] [Abstract][Full Text] [Related]
2. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex.
Volkow ND; Chang L; Wang GJ; Fowler JS; Ding YS; Sedler M; Logan J; Franceschi D; Gatley J; Hitzemann R; Gifford A; Wong C; Pappas N
Am J Psychiatry; 2001 Dec; 158(12):2015-21. PubMed ID: 11729018
[TBL] [Abstract][Full Text] [Related]
3. PET dopamine D2 receptors and susceptibility to methamphetamine psychosis.
Iyo M
Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():652A-653A. PubMed ID: 1354071
[No Abstract] [Full Text] [Related]
4. No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone.
Nordström AL; Farde L; Eriksson L; Halldin C
Psychiatry Res; 1995 Aug; 61(2):67-83. PubMed ID: 7480390
[TBL] [Abstract][Full Text] [Related]
5. Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers.
Volkow ND; Chang L; Wang GJ; Fowler JS; Franceschi D; Sedler MJ; Gatley SJ; Hitzemann R; Ding YS; Wong C; Logan J
Am J Psychiatry; 2001 Mar; 158(3):383-9. PubMed ID: 11229978
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of age-related changes in serotonin 5-HT2 and dopamine D2 receptor availability in healthy human subjects.
Wang GJ; Volkow ND; Logan J; Fowler JS; Schlyer D; MacGregor RR; Hitzemann RJ; Gur RC; Wolf AP
Life Sci; 1995; 56(14):PL249-53. PubMed ID: 7475891
[TBL] [Abstract][Full Text] [Related]
7. PET measurement of neuroreceptor occupancy by typical and atypical neuroleptics.
Goyer PF; Berridge MS; Morris ED; Semple WE; Compton-Toth BA; Schulz SC; Wong DF; Miraldi F; Meltzer HY
J Nucl Med; 1996 Jul; 37(7):1122-7. PubMed ID: 8965181
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D2 receptor density estimates in schizophrenia: a positron emission tomography study with 11C-N-methylspiperone.
Tune LE; Wong DF; Pearlson G; Strauss M; Young T; Shaya EK; Dannals RF; Wilson AA; Ravert HT; Sapp J
Psychiatry Res; 1993 Dec; 49(3):219-37. PubMed ID: 7909948
[TBL] [Abstract][Full Text] [Related]
9. The detection of age-related decrease of dopamine D1, D2 and serotonin 5-HT2 receptors in living human brain.
Iyo M; Yamasaki T
Prog Neuropsychopharmacol Biol Psychiatry; 1993 May; 17(3):415-21. PubMed ID: 8475323
[TBL] [Abstract][Full Text] [Related]
10. MDMA-evoked changes in [11C]raclopride and [11C]NMSP binding in living pig brain.
Rosa-Neto P; Gjedde A; Olsen AK; Jensen SB; Munk OL; Watanabe H; Cumming P
Synapse; 2004 Sep; 53(4):222-33. PubMed ID: 15266554
[TBL] [Abstract][Full Text] [Related]
11. Relationship of Alexithymia Ratings to Dopamine D2-type Receptors in Anterior Cingulate and Insula of Healthy Control Subjects but Not Methamphetamine-Dependent Individuals.
Okita K; Ghahremani DG; Payer DE; Robertson CL; Mandelkern MA; London ED
Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26657175
[TBL] [Abstract][Full Text] [Related]
12. PET measurement of D2 and S2 receptor binding of 3-N-[( 2'-18F]fluoroethyl)spiperone in baboon brain.
Coenen HH; Wienhard K; Stöcklin G; Laufer P; Hebold I; Pawlik G; Heiss WD
Eur J Nucl Med; 1988; 14(2):80-7. PubMed ID: 2968911
[TBL] [Abstract][Full Text] [Related]
13. Striatal [11C]-N-methyl-spiperone binding in patients with focal dystonia (torticollis) using positron emission tomography.
Leenders K; Hartvig P; Forsgren L; Holmgren G; Almay B; Eckernäs SA; Lundqvist H; Långström B
J Neural Transm Park Dis Dement Sect; 1993; 5(2):79-87. PubMed ID: 8101445
[TBL] [Abstract][Full Text] [Related]
14. Use of positron emission tomography to measure the effects of nalmefene on D1 and D2 dopamine receptors in rat brain.
Unterwald EM; Tsukada H; Kakiuchi T; Kosugi T; Nishiyama S; Kreek MJ
Brain Res; 1997 Nov; 775(1-2):183-8. PubMed ID: 9439841
[TBL] [Abstract][Full Text] [Related]
15. Ketamine increases the striatal N-[11C]methylspiperone binding in vivo: positron emission tomography study using conscious rhesus monkey.
Onoe H; Inoue O; Suzuki K; Tsukada H; Itoh T; Mataga N; Watanabe Y
Brain Res; 1994 Nov; 663(2):191-8. PubMed ID: 7874501
[TBL] [Abstract][Full Text] [Related]
16. Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone.
Leysen JE; Van Gompel P; Gommeren W; Woestenborghs R; Janssen PA
Psychopharmacology (Berl); 1986; 88(4):434-44. PubMed ID: 3010361
[TBL] [Abstract][Full Text] [Related]
17. Effect of amphetamine-induced dopamine release on radiotracer binding to D1 and D2 receptors in rat brain striatal slices.
Gifford AN; Park MH; Kash TL; Herman LM; Park EH; Gatley SJ; Volkow ND
Naunyn Schmiedebergs Arch Pharmacol; 2000 Nov; 362(4-5):413-8. PubMed ID: 11111836
[TBL] [Abstract][Full Text] [Related]
18. 5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone.
Nyberg S; Farde L; Eriksson L; Halldin C; Eriksson B
Psychopharmacology (Berl); 1993; 110(3):265-72. PubMed ID: 7530376
[TBL] [Abstract][Full Text] [Related]
19. Sustained withdrawal allows normalization of in vivo [11C]N-methylspiperone dopamine D2 receptor binding after chronic binge cocaine: a positron emission tomography study in rats.
Maggos CE; Tsukada H; Kakiuchi T; Nishiyama S; Myers JE; Kreuter J; Schlussman SD; Unterwald EM; Ho A; Kreek MJ
Neuropsychopharmacology; 1998 Aug; 19(2):146-53. PubMed ID: 9629568
[TBL] [Abstract][Full Text] [Related]
20. PET evidence that loxapine is an equipotent blocker of 5-HT2 and D2 receptors: implications for the therapeutics of schizophrenia.
Kapur S; Zipursky R; Remington G; Jones C; McKay G; Houle S
Am J Psychiatry; 1997 Nov; 154(11):1525-9. PubMed ID: 9356559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
